Ellington Management Group’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-10,600
Closed -$129K 732
2019
Q1
$129K Buy
+10,600
New +$132K 0.02% 515
2018
Q2
Sell
-11,700
Closed -$430K 773
2018
Q1
$430K Buy
+11,700
New +$426K 0.03% 460
2016
Q2
Sell
-5,800
Closed -$239K 443
2016
Q1
$239K Buy
+5,800
New +$227K 0.1% 305
2014
Q3
Sell
-18,000
Closed -$406K 438
2014
Q2
$406K Buy
+18,000
New +$450K 0.19% 156

Other funds holding PRTA

Ellington Management Group's PRTA Position: Q2 2019 in Review

Ellington Management Group sold out of Prothena Corp (PRTA) in Q2 2019, closing a stake of 10,600 shares — an estimated $129K sold.

Ellington Management Group first reported a position in PRTA in Q2 2014 and held it in 4 quarters. The position peaked at $430K in Q1 2018. 138 funds tracked by Wall St. Rank hold PRTA as of Q2 2019.

  • Ellington Management Group reported no remaining Prothena Corp position as of Q2 2019 after selling out during the quarter.
  • Ellington Management Group sold 10,600 Prothena Corp shares in Q2 2019, an estimated $129K.
  • Ellington Management Group first reported a position in Prothena Corp in Q2 2014 and held it in 4 quarters.
  • Ellington Management Group's Prothena Corp position peaked at $430K in Q1 2018.
  • 138 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2019.

Based on Ellington Management Group's 13F filing for Q2 2019, filed 14 Aug 2019.